RCEL
RCEL
NASDAQ · Biotechnology

Avita Medical Inc

$3.90
-0.03 (-0.76%)
As of Feb 8, 2:10 PM ET ·
Analyst Consensus
Strong Buy
12
Analysts
Moderate
Coverage
Buy 9 75%
Hold 3 25%
Sell 0 0%
Price Target
Analyst Price Target +787.4% upside
Low Target $23.82
Average Target $34.61
High Target $34.97
Current Price $3.90
Current
$3.90
Target
$34.61
$23.82 $34.61 avg $34.97
Scenario Analysis
Bear Case
$23.82
510.8%
Low target
Base Case
$34.61
+787.4%
Avg target
Bull Case
$34.97
+796.7%
High target
Risk/Reward
1.6x
Balanced
Price in Context
52-Week High
$36.80
-89.4% from high
52-Week Low
$19.49
+-80.0% from low
Target vs 52W High
$34.61
-6.0% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
Buy 37 68% $257.58 +15.3%
AMGN
Amgen Inc
Hold 41 54% $190.87 -50.3%
GILD
Gilead Sciences Inc
Strong Buy 37 81% $362.68 +137.8%
VRTX
Vertex Pharmaceuticals Inc
Strong Buy 39 77% $438.34 -8.3%
REGN
Regeneron Pharmaceuticals
Strong Buy 36 75% $76.80 -90.2%
ALNY
Alnylam Pharmaceuticals Inc
Strong Buy 36 75% $102.31 -68.8%
INSM
Insmed Inc
Strong Buy 27 93% $143.40 -4.3%
BIIB
Biogen Inc
Hold 42 48% $91.45 -54.5%